PDB Short entry for 1QMB HEADER SERINE PROTEASE INHIBITOR 24-SEP-99 1QMB TITLE CLEAVED ALPHA-1-ANTITRYPSIN POLYMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTITRYPSIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 49-69,71-302,304-376; COMPND 5 SYNONYM: ALPHA-1-PROTEINASE INHIBITOR, ALPHA-1-PI; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ALPHA-1-ANTITRYPSIN; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 377-418; COMPND 12 SYNONYM: ALPHA-1-PROTEINASE INHIBITOR, ALPHA-1-PI; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE PROTEASE INHIBITOR, SERPIN, ANTITRYPSIN, POLYMER, KEYWDS 2 CLEAVED EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HUNTINGTON,N.S.PANNU,B.HAZES,R.J.READ,D.A.LOMAS, AUTHOR 2 R.W.CARRELL REVDAT 2 24-FEB-09 1QMB 1 VERSN REVDAT 1 06-FEB-00 1QMB 0 JRNL AUTH J.A.HUNTINGTON,N.S.PANNU,B.HAZES,R.J.READ, JRNL AUTH 2 D.A.LOMAS,R.W.CARRELL JRNL TITL A 2.6A STRUCTURE OF A SERPIN POLYMER AND JRNL TITL 2 IMPLICATIONS FOR CONFORMATIONAL DISEASE JRNL REF J.MOL.BIOL. V. 293 449 1999 JRNL REFN ISSN 0022-2836 JRNL PMID 10543942 JRNL DOI 10.1006/JMBI.1999.3184 REMARK 2 REMARK 2 RESOLUTION. 2.6 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1038103.31 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 73.8 REMARK 3 NUMBER OF REFLECTIONS : 17423 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 875 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.57 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.73 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 13.2 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 501 REMARK 3 BIN R VALUE (WORKING SET) : 0.409 REMARK 3 BIN FREE R VALUE : 0.373 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.9 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 26 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.073 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2873 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 17 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.0 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06 REMARK 3 B22 (A**2) : 0.06 REMARK 3 B33 (A**2) : -0.12 REMARK 3 B12 (A**2) : -4.68 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM SIGMAA (A) : 0.81 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.73 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.2 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.6 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.59 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 4.00 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 6.25 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 8.74 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 11.86 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.321472 REMARK 3 BSOL : 50.9487 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QMB COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-SEP-99. REMARK 100 THE PDBE ID CODE IS EBI-4086. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : SI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17423 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 27.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 71.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.20900 REMARK 200 R SYM (I) : 0.18300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.7300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 12.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : 1.00000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 0.9 REMARK 200 STARTING MODEL: PDB ETRY 7API REMARK 200 REMARK 200 REMARK: MOLECULAR REPLACEMENT WAS CONDUCTED IN THE ABSENCE OF REMARK 200 S4A REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M TRI-SODIUM CITRATE, REMARK 280 0.1M TRIS, PH 8.5, 30% PEG 400 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.88333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 73.76667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 73.76667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 36.88333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -51.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CRYSTAL TRIALS WERE SET UP FOR S195A THROMBIN AND M358R REMARK 400 ALPHA-1-ANTITRYPSIN. THE CRYSTALS CONTAINED ONLY P7-P6 REMARK 400 CLEAVED ALPHA-1-ANTITRYPSIN AND THE REMAINING MOTHERLIQOUR REMARK 400 WAS PREDOMINANTLY S195A THROMBIN. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 125 CG CD CE NZ REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 ARG A 178 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 196 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 233 CG CD CE NZ REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 ASP A 280 CG OD1 OD2 REMARK 470 LYS B 365 CG CD CE NZ REMARK 470 LYS B 380 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 70 -139.00 51.90 REMARK 500 HIS A 73 -70.14 -70.10 REMARK 500 GLU A 86 -73.12 129.86 REMARK 500 ASP A 107 44.44 -80.03 REMARK 500 SER A 108 -47.90 55.27 REMARK 500 LEU A 126 -174.34 -62.73 REMARK 500 ASP A 128 -60.83 -16.85 REMARK 500 VAL A 170 -111.90 -67.20 REMARK 500 ARG A 196 77.25 -152.38 REMARK 500 PRO A 197 173.31 -55.64 REMARK 500 VAL A 213 31.95 -152.09 REMARK 500 LYS A 259 10.29 -150.33 REMARK 500 LEU A 299 3.07 -59.34 REMARK 500 THR A 309 -39.24 -130.49 REMARK 500 GLU A 324 -104.26 -45.86 REMARK 500 LYS A 331 165.60 179.21 REMARK 500 ASP A 341 -162.75 -123.65 REMARK 500 ARG B 358 -135.84 -93.02 REMARK 500 SER B 359 -10.06 -162.85 REMARK 500 ILE B 360 80.79 45.70 REMARK 500 ASN B 390 98.58 -164.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7API RELATED DB: PDB REMARK 900 MODIFIED ALPHA-1-ANTITRYPSIN / MODIFIED ALPHA-1-PROTEINASE REMARK 900 INHIBITOR (TETRAGONAL FORM 1) REMARK 900 RELATED ID: 8API RELATED DB: PDB REMARK 900 MODIFIED ALPHA-1-ANTITRYPSIN / MODIFIED ALPHA-1-PROTEINASE REMARK 900 INHIBITOR (HEXAGONAL) REMARK 900 RELATED ID: 9API RELATED DB: PDB REMARK 900 MODIFIED ALPHA-1-ANTITRYPSIN / MODIFIED ALPHA-1-PROTEINASE REMARK 900 INHIBITOR (TETRAGONAL FORM 2) REMARK 900 RELATED ID: 1PSI RELATED DB: PDB REMARK 900 INTACT RECOMBINED ALPHA-1-ANTITRYPSIN MUTANT PHE 51 TO LEU REMARK 900 RELATED ID: 2PSI RELATED DB: PDB REMARK 900 INTACT WILDTYPE RECOMBINANT ALPHA-1-ANTITRYPSIN REMARK 900 RELATED ID: 1KCT RELATED DB: PDB REMARK 900 ALPHA1-ANTITRYPSIN REMARK 900 RELATED ID: 1ATU RELATED DB: PDB REMARK 900 UNCLEAVED ALPHA-1-ANTITRYPSIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 PREVIOUSLY UNIDENTIFIED CLEAVAGE SITE REMARK 999 CHAIN BREAK SER 45 A --- SER 47 A MISSING RESIDUE ASN 46 A REMARK 999 CHAIN BREAK ASN 278 A --- ASP 280 A MISSING RESIDUE GLU 279 A DBREF 1QMB A 25 45 UNP P01009 A1AT_HUMAN 49 69 DBREF 1QMB A 47 278 UNP P01009 A1AT_HUMAN 71 302 DBREF 1QMB A 280 352 UNP P01009 A1AT_HUMAN 304 376 DBREF 1QMB B 353 394 UNP P01009 A1AT_HUMAN 377 418 SEQADV 1QMB ALA A 91 UNP P01009 GLN 115 CONFLICT SEQADV 1QMB ARG B 358 UNP P01009 MET 382 ENGINEERED SEQADV 1QMB ALA B 368 UNP P01009 LYS 392 CONFLICT SEQRES 1 A 326 LYS ILE THR PRO ASN LEU ALA GLU PHE ALA PHE SER LEU SEQRES 2 A 326 TYR ARG GLN LEU ALA HIS GLN SER SER THR ASN ILE PHE SEQRES 3 A 326 PHE SER PRO VAL SER ILE ALA THR ALA PHE ALA MET LEU SEQRES 4 A 326 SER LEU GLY THR LYS ALA ASP THR HIS ASP GLU ILE LEU SEQRES 5 A 326 GLU GLY LEU ASN PHE ASN LEU THR GLU ILE PRO GLU ALA SEQRES 6 A 326 ALA ILE HIS GLU GLY PHE GLN GLU LEU LEU ARG THR LEU SEQRES 7 A 326 ASN GLN PRO ASP SER GLN LEU GLN LEU THR THR GLY ASN SEQRES 8 A 326 GLY LEU PHE LEU SER GLU GLY LEU LYS LEU VAL ASP LYS SEQRES 9 A 326 PHE LEU GLU ASP VAL LYS LYS LEU TYR HIS SER GLU ALA SEQRES 10 A 326 PHE THR VAL ASN PHE GLY ASP THR GLU GLU ALA LYS LYS SEQRES 11 A 326 GLN ILE ASN ASP TYR VAL GLU LYS GLY THR GLN GLY LYS SEQRES 12 A 326 ILE VAL ASP LEU VAL LYS GLU LEU ASP ARG ASP THR VAL SEQRES 13 A 326 PHE ALA LEU VAL ASN TYR ILE PHE PHE LYS GLY LYS TRP SEQRES 14 A 326 GLU ARG PRO PHE GLU VAL LYS ASP THR GLU GLU GLU ASP SEQRES 15 A 326 PHE HIS VAL ASP GLN VAL THR THR VAL LYS VAL PRO MET SEQRES 16 A 326 MET LYS ARG LEU GLY MET PHE ASN ILE GLN HIS CYS LYS SEQRES 17 A 326 LYS LEU SER SER TRP VAL LEU LEU MET LYS TYR LEU GLY SEQRES 18 A 326 ASN ALA THR ALA ILE PHE PHE LEU PRO ASP GLU GLY LYS SEQRES 19 A 326 LEU GLN HIS LEU GLU ASN GLU LEU THR HIS ASP ILE ILE SEQRES 20 A 326 THR LYS PHE LEU GLU ASN ASP ARG ARG SER ALA SER LEU SEQRES 21 A 326 HIS LEU PRO LYS LEU SER ILE THR GLY THR TYR ASP LEU SEQRES 22 A 326 LYS SER VAL LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SEQRES 23 A 326 SER ASN GLY ALA ASP LEU SER GLY VAL THR GLU GLU ALA SEQRES 24 A 326 PRO LEU LYS LEU SER LYS ALA VAL HIS LYS ALA VAL LEU SEQRES 25 A 326 THR ILE ASP GLU LYS GLY THR GLU ALA ALA GLY ALA MET SEQRES 26 A 326 PHE SEQRES 1 B 42 LEU GLU ALA ILE PRO ARG SER ILE PRO PRO GLU VAL LYS SEQRES 2 B 42 PHE ASN ALA PRO PHE VAL PHE LEU MET ILE GLU GLN ASN SEQRES 3 B 42 THR LYS SER PRO LEU PHE MET GLY LYS VAL VAL ASN PRO SEQRES 4 B 42 THR GLN LYS FORMUL 3 HOH *17(H2 O1) HELIX 1 1 ILE A 26 SER A 45 1 20 HELIX 2 2 SER A 53 SER A 65 1 13 HELIX 3 3 LEU A 66 THR A 68 5 3 HELIX 4 4 LYS A 69 LEU A 80 1 12 HELIX 5 5 PRO A 88 ASN A 104 1 17 HELIX 6 6 VAL A 127 TYR A 138 1 12 HELIX 7 7 ASP A 149 THR A 165 1 17 HELIX 8 8 LYS A 259 GLU A 266 1 8 HELIX 9 9 THR A 268 ASN A 278 1 11 HELIX 10 10 LEU A 299 GLN A 305 1 7 HELIX 11 11 THR A 309 SER A 313 5 5 SHEET 1 A 6 GLU A 141 VAL A 145 0 SHEET 2 A 6 GLN A 111 SER A 121 1 N LEU A 118 O GLU A 141 SHEET 3 A 6 PHE A 182 LYS A 193 -1 N LYS A 191 O GLN A 111 SHEET 4 A 6 GLY A 344 PHE A 352 -1 N MET A 351 O ASN A 186 SHEET 5 A 6 VAL A 333 ILE A 340 -1 N THR A 339 O GLU A 346 SHEET 6 A 6 LEU A 291 ASP A 298 -1 N TYR A 297 O HIS A 334 SHEET 1 B 3 ARG A 282 PRO A 289 0 SHEET 2 B 3 THR A 214 PHE A 227 -1 N PHE A 227 O ARG A 282 SHEET 3 B 3 GLU A 204 ASP A 211 -1 N ASP A 211 O THR A 214 SHEET 1 C 3 GLN A 230 CYS A 232 0 SHEET 2 C 3 SER A 237 TYR A 244 -1 N VAL A 239 O GLN A 230 SHEET 3 C 3 ALA A 248 PRO A 255 -1 N LEU A 254 O TRP A 238 SHEET 1 D 2 PHE B 370 GLU B 376 0 SHEET 2 D 2 SER B 381 VAL B 388 -1 N VAL B 388 O PHE B 370 CRYST1 108.590 108.590 110.650 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009209 0.005317 0.000000 0.00000 SCALE2 0.000000 0.010633 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009037 0.00000